---
layout: default
title: 2 3 7 8-Tetrachlorodibenzo-P-Dioxin Bromine Chlori
parent: 僅模型預測 (L5)
nav_order: 23
evidence_level: L5
indication_count: 0
---

# 2 3 7 8-Tetrachlorodibenzo-P-Dioxin Bromine Chlori
{: .fs-9 }

證據等級: **L5** | 預測適應症: **0** 個
{: .fs-6 .fw-300 }

---

## 目錄
{: .no_toc .text-delta }

1. TOC
{:toc}

---

<div id="pharmacist">

## 藥師評估報告

</div>

# Chemical Compound Mixture: No Drug Repurposing Evaluation Available

## One-Sentence Summary

The submitted entry contains a semicolon-delimited list of environmental contaminants and industrial chemicals — including 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), chloroform, lead, fluoride, phenol, and others — none of which constitute a single pharmaceutical drug entity.
The TxGNN model returned **no predicted indications**, and no US market authorization exists for this compound mixture.
A meaningful repurposing evaluation cannot be performed without first resolving the data entry issue.

---

## Quick Overview

| Item | Content |
|------|---------|
| Original Indication | None on record |
| Predicted New Indication | None — TxGNN returned no candidates |
| TxGNN Prediction Score | N/A |
| Evidence Level | Not evaluable |
| US Market Status | Not marketed |
| Number of NDAs | 0 |
| Recommended Decision | **Hold** |

---

## Why No Prediction is Available

The `drug.inn` field contains 13 distinct chemical identifiers separated by semicolons. These are not components of a single approved pharmaceutical formulation; they are a heterogeneous mix of:

| Compound | Classification |
|----------|---------------|
| 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) | Persistent organic pollutant / known human carcinogen (IARC Group 1) |
| Chloroform | Industrial solvent / historical anaesthetic (withdrawn) |
| Lead | Heavy metal / environmental neurotoxin |
| Sodium fluoride / Fluoride ion | Mineral supplement at low doses; toxic at high doses |
| Phenol | Antiseptic / industrial chemical |
| Copper / Iron | Essential trace elements |
| Bromine / Chlorine | Halogen elements |
| Fenson | Organochlorine pesticide (largely obsolete) |
| Pentaerythritol tetrakis(3-mercaptopropionate) | Polymer crosslinker / industrial additive |

Because the TxGNN knowledge graph matches on a single INN to DrugBank node mapping, a compound string of this form cannot be resolved to any known drug entity. The pipeline returned zero predicted indications as a direct consequence of this mapping failure, not because the compounds have been evaluated and found unsuitable.

---

## Conclusion and Next Steps

**Decision: Hold**

**Rationale:**
This entry does not represent a viable drug repurposing candidate. The input string appears to be a data ingestion artefact — possibly a row from an environmental exposure registry or a multi-ingredient raw-material record — that was inadvertently passed through the repurposing pipeline without prior deduplication or entity resolution.

**To proceed, the following actions are required:**

1. **Identify the intended query** — Determine which single active pharmaceutical ingredient (API) was meant to be evaluated. If the original source record contains a mixture, each API should be submitted as a separate, individual query.
2. **Re-run entity resolution** — After isolating a single INN, re-query DrugBank to obtain a valid `drugbank_id` before re-entering the TxGNN pipeline.
3. **Assess regulatory context** — If any component (e.g., sodium fluoride as a dental therapeutic) is the true subject of interest, retrieve its standalone TFDA/NDA records and resubmit.
4. **Flag for data quality review** — Add a deduplication and format-validation step upstream in the pipeline to prevent non-drug chemical strings from reaching the prediction stage.

> ⚠️ **Note:** Several compounds in this entry (TCDD, chloroform, lead) are classified as human carcinogens or reproductive toxicants. They are subject to hazardous substance regulations and are not candidates for conventional drug repurposing without extraordinary toxicological justification.
## Disclaimer

This content is for research purposes only and does not constitute medical advice.
Clinical validation is required before any clinical application.

---

